EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Kailera Therapeutics is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions.
Keep an Eye on These 15 Biotech Companies in 2026
Early-Stage Biotechs Suffer in 2025 As VC Shuns Risk: PitchBook
Labiotech’s 15 Biopharma Companies to Watch in 2026
Nine Biotech Companies that Could Revolutionize Obesity Treatments
Hengrui, Kailera Tout Positive Results for Dual-Acting Obesity Pill
2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity